Cervical cancer in the Autonomous Province of Vojvodina, Serbia, 2016-2021

Author:

Ljubicic Stefan1,Strbac Mirjana1ORCID,Nikolic Natasa2ORCID,Susnjevic Sonja2ORCID,Dugandzija Tihomir3,Petrovic Vladimir2ORCID,Ristic Mioljub2ORCID

Affiliation:

1. Institute of Public Health of Vojvodina, Novi Sad, Serbia

2. Institute of Public Health of Vojvodina, Novi Sad, Serbia + Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

3. Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia + Oncology Institute of Vojvodina, Sremska Kamenica, Serbia

Abstract

Background: Cervical cancer is a major global health problem, and one of the most common causes of cancer in women. This descriptive epidemiological study aimed to provide an overview of the cervical cancer incidence and mortality in Vojvodina. Methods: The data from the Serbian Cancer Registry regarding the cervical cancer incidence and mortality for the period 2016?2021 were analyzed. Results: During the observed 6-year period, the average age-standardized incidence rates of cervical cancer in Vojvodina and Serbia were 20.4 and 19.1 per 100,000 women, respectively. The average age-standardized incidence rates by the district of Vojvodina ranged from 16.8 to 30.2/100,000. The average age-standardized cervical cancer mortality rate in Vojvodina and Serbia was 7.0 and 6.6/100,000, respectively. The average mortality rates by the district of Vojvodina ranged between 5.6/100,000 and 9.9/100,000. Conclusion: The cervical cancer incidence and mortality rates in Vojvodina exhibited significant variation across different districts and observed years, with their average values surpassing the national average. To improve the epidemiological situation of cervical cancer in Vojvodina, it is imperative to enhance the implementation of organized screening at the district level, coupled with intensified efforts to promote HPV vaccination throughout Vojvodina. Additionally, more research on screening coverage and vaccination rates and improved reporting cervical cancer cases and deaths are needed.

Publisher

National Library of Serbia

Reference32 articles.

1. Ferlay J, Ervik M, Lam F, Laversanne M, Colombet N, Mery L, et al. Global Cancer Observatory: Cancer Today (version 1.1) [Internet]. [cited 2024 Mar 20]. Available from: https://gco.iarc.who.int/today/

2. Buskwofie A, David-West G, Clare CA. A Review of Cervical Cancer: Incidence and Disparities. J Natl Med Assoc. 2020 Apr;112(2):229-32. doi: 10.1016/j.jnma.2020.03.002

3. Bruni L, Albero G, Serrano B, Mena M, Collado J, Gómez D, et al. ICO/IARC information centre on HPV and cancer (HPV information centre). Human Papillomavirus and Related Diseases in the World. [Internet]. 2023 Mar [cited 2024 Mar 20]. Available from: https://hpvcentre.net/statistics/reports/XWX.pdf

4. World Health Organization. Cervical cancer [Internet]. 2024 [cited 2024 Mar 20]. Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer

5. Lee L, Garland SM. Human papillomavirus vaccination: the population impact. F1000Research. 2017 Jun 12;6:866. doi:10.12688/f1000research.10691.1

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3